<DOC>
	<DOCNO>NCT02285959</DOCNO>
	<brief_summary>The high-grade malignant brain tumor glioblastoma multiforme ( GBM ) comprise majority primary brain tumor adult . This group tumor also exhibit aggressive behavior , result median overall survival duration 9-12 month GBM . Initial therapy consist surgical resection , external beam radiation . Currently , patient experience recurrence first-line therapy , improvement first-line salvage therapy critical enhance quality-of-life prolonging survival . Superselective Intraarterial Cerebral Infusion ( SIACI ) technique effectively increase concentration drug deliver brain spar body systemic side effect . This technique thread tiny catheter patient 's femoral artery leg , body neck brain . Once catheter reach brain , chemotherapy release blood vessel fee tumor .</brief_summary>
	<brief_title>Super-Selective Intraarterial Intracranial Infusion Bevacizumab ( Avastin ) Glioblastoma Multiforme</brief_title>
	<detailed_description />
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>Histologically confirm diagnosis GBM Grade IV GBM tumor recur total resection Age &gt; 18 year At least four week follow recent surgery Patients must Karnofsky performance status ≥60 % expect survival ≥ three month . No IV chemotherapy three week prior treatment research protocol external beam radiation four week prior treatment research protocol . Patients must adequate hematologic reserve Preenrollment coagulation parameter ( PT PTT ) must adequate . Patients must agree use medically effective method contraception period three month treatment period . A pregnancy test perform premenopausal female childbearing potential immediately prior entry research study . Patients must able understand give write informed consent . Informed consent must obtain time patient screening . Women pregnant lactating . Women childbearing potential fertile men inform potential risk procreation participate research trial advise must use effective contraception period three month treatment period . Patients significant intercurrent medical psychiatric condition would place increased risk affect ability receive comply treatment posttreatment clinical monitoring .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>